3,630 Shares in Tenet Healthcare Corporation $THC Acquired by Private Advisory Group LLC

Private Advisory Group LLC bought a new stake in shares of Tenet Healthcare Corporation (NYSE:THC – Free Report) in the 3rd quarter, HoldingsChannel.com reports. The fund bought 3,630 shares of the company’s stock, valued at approximately $928,000.

Several other large investors have also recently made changes to their positions in THC. V Square Quantitative Management LLC purchased a new stake in Tenet Healthcare during the third quarter worth $26,000. Mather Group LLC. increased its holdings in Tenet Healthcare by 126.9% in the third quarter. Mather Group LLC. now owns 118 shares of the company’s stock valued at $30,000 after buying an additional 66 shares in the last quarter. Trust Co. of Vermont purchased a new position in Tenet Healthcare in the second quarter valued at $37,000. MADDEN SECURITIES Corp acquired a new position in shares of Tenet Healthcare in the third quarter worth about $38,000. Finally, Compass Financial Management LLC acquired a new position in shares of Tenet Healthcare in the second quarter worth about $57,000. 95.44% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Tenet Healthcare

In related news, Director Cecil Haney sold 1,300 shares of Tenet Healthcare stock in a transaction dated Monday, August 24th. The stock was sold at an average price of $278.03, for a total value of $361,439.00. Following the sale, the director directly owned 12,553 shares in the company, valued at approximately $3,490,110.59. The trade was a 9.38% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CEO Saumya Sutaria sold 50,000 shares of the business’s stock in a transaction that occurred on Monday, August 24th. The stock was sold at an average price of $278.71, for a total value of $13,935,500.00. Following the sale, the chief executive officer owned 483,564 shares of the company’s stock, valued at approximately $134,774,122.44. This trade represents a 9.37% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 99,462 shares of company stock worth $27,081,234 in the last three months. 0.97% of the stock is owned by corporate insiders.

Tenet Healthcare Stock Performance

NYSE:THC opened at $286.34 on Monday. The company has a debt-to-equity ratio of 1.76, a quick ratio of 1.52 and a current ratio of 1.58. The stock has a market capitalization of $22.79 billion, a PE ratio of 8.30, a P/E/G ratio of 1.53 and a beta of 1.20. Tenet Healthcare Corporation has a fifty-two week low of $157.58 and a fifty-two week high of $301.44. The company has a fifty day moving average of $267.83 and a two-hundred day moving average of $224.88.

Tenet Healthcare (NYSE:THC – Get Free Report) last announced its earnings results on Thursday, October 29th. The company reported $6.64 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.68 by $1.96. The business had revenue of $6.28 billion for the quarter, compared to analyst estimates of $5.49 billion. Tenet Healthcare had a net margin of 13.09% and a return on equity of 28.22%. The company’s revenue for the quarter was up 6.5% compared to the same quarter last year. During the same quarter last year, the business earned $3.70 earnings per share. As a group, research analysts forecast that Tenet Healthcare Corporation will post 22.32 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of equities research analysts have recently commented on THC shares. Mizuho set a $305.00 target price on Tenet Healthcare in a research report on Monday, November 2nd. Weiss Ratings raised Tenet Healthcare from a “buy (b-)” rating to a “buy (b)” rating in a report on Thursday, October 8th. BMO Capital Markets began coverage on Tenet Healthcare in a research report on Tuesday, September 22nd. They set a “market perform” rating and a $265.00 price target on the stock. Robert W. Baird raised their price objective on Tenet Healthcare from $210.00 to $280.00 and gave the company a “neutral” rating in a report on Tuesday, July 28th. Finally, Zacks Research cut Tenet Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, September 29th. Nineteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $296.65.

Check Out Our Latest Analysis on Tenet Healthcare

About Tenet Healthcare

(Free Report)

Tenet Healthcare Corporation is a U.S.-based healthcare services company that operates acute care hospitals and provides related inpatient and outpatient services. Its hospitals offer services across areas such as emergency care, surgery, imaging and specialty treatment. Through its subsidiary United Surgical Partners International (USPI), Tenet also operates ambulatory surgery centers and surgical hospitals, providing outpatient surgical and procedural care. The company’s Conifer Health Solutions business provides revenue cycle management and other administrative services to healthcare providers.

See Also

Want to see what other hedge funds are holding THC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tenet Healthcare Corporation (NYSE:THC – Free Report).

Institutional Ownership by Quarter for Tenet Healthcare (NYSE:THC)

Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.